ODYSSEY HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 USD | +3.45% |
|
0.00% | -70.00% |
Valuation
| Fiscal Period: Julio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 191.7 | 120.3 | 41.56 | 41.94 | 14.72 | 11.06 |
| Enterprise Value (EV) 1 | 192.4 | 120.9 | 41.78 | 42.12 | 16.18 | 13.17 |
| P/E ratio | -388 x | -273 x | -9.55 x | -2.84 x | -1.99 x | -1.95 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -691 x | -359 x | -10.9 x | -6.57 x | -2 x | -2.56 x |
| EV / FCF | -1,383 x | -560 x | 44.5 x | 133 x | -37.2 x | 21.3 x |
| FCF Yield | -0.07% | -0.18% | 2.25% | 0.75% | -2.69% | 4.69% |
| Price to Book | -120 x | 6.8 x | -64.8 x | -16.1 x | -3.17 x | -1.8 x |
| Nbr of stocks (in thousands) | 1,19,840 | 68,745 | 87,170 | 81,891 | 77,861 | 79,068 |
| Reference price 2 | 1.600 | 1.750 | 0.4768 | 0.5121 | 0.1890 | 0.1399 |
| Announcement Date | 12/12/18 | 23/10/19 | 16/11/20 | 29/10/21 | 31/10/22 | 30/10/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Julio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | - | - | - |
| EBITDA 1 | -0.2784 | -0.3368 | -3.836 | -6.415 | -8.104 | -5.141 |
| EBIT 1 | -0.289 | -0.3781 | -3.847 | -6.421 | -8.107 | -5.144 |
| Operating Margin | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -0.4831 | -0.4484 | -4.349 | -16.88 | -8.444 | -5.919 |
| Net income 1 | -0.4831 | -0.4484 | -4.349 | -16.88 | -8.444 | -5.919 |
| Net margin | - | - | - | - | - | - |
| EPS 2 | -0.004124 | -0.006415 | -0.0499 | -0.1801 | -0.0949 | -0.0716 |
| Free Cash Flow 1 | -0.1391 | -0.2158 | 0.938 | 0.3164 | -0.4349 | 0.6179 |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 12/12/18 | 23/10/19 | 16/11/20 | 29/10/21 | 31/10/22 | 30/10/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: Julio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.63 | 0.62 | 0.21 | 0.18 | 1.46 | 2.11 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -2.267 x | -1.835 x | -0.0555 x | -0.028 x | -0.1801 x | -0.41 x |
| Free Cash Flow 1 | -0.14 | -0.22 | 0.94 | 0.32 | -0.43 | 0.62 |
| ROE (net income / shareholders' equity) | 78% | -4.16% | 698% | 988% | 228% | 110% |
| ROA (Net income/ Total Assets) | -193% | -2% | -749% | -1,121% | -859% | -627% |
| Assets 1 | 0.2497 | 22.47 | 0.5807 | 1.506 | 0.9835 | 0.944 |
| Book Value Per Share 2 | -0.0100 | 0.2600 | -0.0100 | -0.0300 | -0.0600 | -0.0800 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0.0100 | 0 | 0 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 12/12/18 | 23/10/19 | 16/11/20 | 29/10/21 | 31/10/22 | 30/10/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- ODYY Stock
- Financials Odyssey Health, Inc.
